TrialProstate cancer and prostatic diseases2023

ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.

Ronald Tutrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.